Inactive Instrument

Other languages Otonomy

Equities

OTIC

US68906L1052

Other languages

Unlock all the news: Be the first to know and act before the market!

Otonomy, Inc. Announces Executive Changes	28/23/28
Otonomy, Inc. Announces Executive Changes	17/23/17
Otonomy Shares to be Suspended From Nasdaq Trading	22/22/22
Otonomy Plans to File for Liquidation; Lays off All Employees; Shares Fall	21/22/21
Otonomy, Inc. Plans Reduce Its Workforce	20/22/20
Otonomy, Inc. Announces Executive Changes	20/22/20
Otonomy, Inc. Announces Termination of David A. Weber as Chief Executive Officer	20/22/20
Otonomy, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11/22/11
Otonomy Sees No Clinically Meaningful Improvement With Higher Doses of OTO-413 in Patients With Hearing Loss -- Shares Nosedive	13/22/13
Otonomy Sees No Clinically Meaningful Improvement With Higher Doses of OTO-413 in Patients With Hearing Loss	13/22/13
Otonomy, Inc Reports Results from Clinical Evaluation of OTO-413 Higher Doses in Patients with Hearing Loss	13/22/13
Otonomy, Inc. Announces Departure of Robert Michael Savel II, as Chief Technical Officer Effective August 15, 2022	10/22/10
Otonomy to Halt Development of Tinnitus Drug After Phase 2 Trial Failed to Meet Endpoints; Shares Hit 52-Week Low	01/22/01
Otonomy Reports Results from Phase 2 Clinical Trial of Oto-313 in Patients with Tinnitus	01/22/01
Otonomy, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	26/22/26
Otonomy, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	10/22/10
Otonomy Says Hearing Loss Treatment Drug Showed Clinical Benefit During Phase 2a Trial	20/22/20
Otonomy, Inc. Reports Positive Top-Line Results from Phase 2a Clinical Trial of OTO-413 in Patients with Hearing Loss	20/22/20
Otonomy, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	01/22/01
Otonomy, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	01/22/01

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Otonomy

Equities

OTIC

US68906L1052

Other languages

Filters